160 related articles for article (PubMed ID: 29985834)
41. [Thyroid associated orbitopathy: from diagnosis to treatment].
Hamédani M; Obéric A
Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
[TBL] [Abstract][Full Text] [Related]
42. Management of strabismus in thyroid eye disease.
Harrad R
Eye (Lond); 2015 Feb; 29(2):234-7. PubMed ID: 25523204
[TBL] [Abstract][Full Text] [Related]
43. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.
Goldstein SM; Katowitz WR; Moshang T; Katowitz JA
Thyroid; 2008 Sep; 18(9):997-9. PubMed ID: 18713025
[TBL] [Abstract][Full Text] [Related]
44. [Graves' Orbitopathy].
Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
[No Abstract] [Full Text] [Related]
45. Thyroid Eye Disease.
Szelog J; Swanson H; Sniegowski MC; Lyon DB
Mo Med; 2022; 119(4):343-350. PubMed ID: 36118816
[TBL] [Abstract][Full Text] [Related]
46. [Graves' ophthalmopathy].
Caballero Mora FJ; Martos Moreno GA; Gutiérrez Partida B; Argente J
An Pediatr (Barc); 2012 Nov; 77(5):355-6. PubMed ID: 22682548
[No Abstract] [Full Text] [Related]
47. Thyroid eye disease.
Cockerham KP; Chan SS
Neurol Clin; 2010 Aug; 28(3):729-55. PubMed ID: 20637998
[TBL] [Abstract][Full Text] [Related]
48. Euthyroid Graves' ophthalmopathy with negative autoantibodies.
Cakir M
J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503
[TBL] [Abstract][Full Text] [Related]
49. [Pathogenetic, clinical and therapeutical features of ophthalmologic involvement in Basedow's disease].
Verraz R
Arch Sci Med (Torino); 1969 Sep; 126(9):699-704. PubMed ID: 17340828
[TBL] [Abstract][Full Text] [Related]
50. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
Azzam I; Tordjman K
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
[TBL] [Abstract][Full Text] [Related]
51. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy.
Wiersinga WM
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():250-3. PubMed ID: 20467372
[TBL] [Abstract][Full Text] [Related]
52. Recurrent Thyroid Eye Disease.
Patel P; Khandji J; Kazim M
Ophthalmic Plast Reconstr Surg; 2015; 31(6):445-8. PubMed ID: 25621464
[TBL] [Abstract][Full Text] [Related]
53. Phenotypes of Thyroid Eye Disease.
Uddin JM; Rubinstein T; Hamed-Azzam S
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S28-S33. PubMed ID: 29905636
[TBL] [Abstract][Full Text] [Related]
54. [Update on endocrine orbitopathy].
Ponto KA; Kahaly GJ; Pitz S
Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
[No Abstract] [Full Text] [Related]
55. [Combined idiopathic orbital inflammation and Graves' orbitopathy].
Ciechanowski PP; Töteberg-Harms M; Pangalu A; Chaloupka K
Klin Monbl Augenheilkd; 2012 Apr; 229(4):466-7. PubMed ID: 22496035
[No Abstract] [Full Text] [Related]
56. Coincidental Optic Nerve Meningioma and Thyroid Eye Disease.
Garg A; Patel P; Lignelli A; Baron E; Kazim M
Ophthalmic Plast Reconstr Surg; 2015; 31(4):e94-5. PubMed ID: 24833445
[TBL] [Abstract][Full Text] [Related]
57. Management of patients with thyroid eye disease.
Karra E; Yousseif A; Rose GE; Baldeweg SE
Br J Hosp Med (Lond); 2016 Jan; 77(1):C6-9. PubMed ID: 26903468
[No Abstract] [Full Text] [Related]
58. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.
Quinn AS; Dujardin LR; Knight B; Benzimra J; Quinn AG; Vaidya B
Int Ophthalmol; 2018 Feb; 38(1):301-306. PubMed ID: 28181061
[TBL] [Abstract][Full Text] [Related]
59. [Ocular myopathies and autoimmunity].
Eckstein A; Esser J
Klin Monbl Augenheilkd; 2014 Sep; 231(9):e47, e49-65; quiz e66-7. PubMed ID: 25116065
[No Abstract] [Full Text] [Related]
60. Grading Severity and Activity in Thyroid Eye Disease.
Dolman PJ
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S34-S40. PubMed ID: 29952931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
